These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12223032)

  • 1. Outcome measures for pediatric spinal muscular atrophy.
    Iannaccone ST;
    Arch Neurol; 2002 Sep; 59(9):1445-50. PubMed ID: 12223032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reliability of 4 outcome measures in pediatric spinal muscular atrophy.
    Iannaccone ST; Hynan LS;
    Arch Neurol; 2003 Aug; 60(8):1130-6. PubMed ID: 12925371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The PedsQL in pediatric patients with Spinal Muscular Atrophy: feasibility, reliability, and validity of the Pediatric Quality of Life Inventory Generic Core Scales and Neuromuscular Module.
    Iannaccone ST; Hynan LS; Morton A; Buchanan R; Limbers CA; Varni JW;
    Neuromuscul Disord; 2009 Dec; 19(12):805-12. PubMed ID: 19846309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reliability of hand-held dynamometry in spinal muscular atrophy.
    Merlini L; Mazzone ES; Solari A; Morandi L
    Muscle Nerve; 2002 Jul; 26(1):64-70. PubMed ID: 12115950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliability of telephone administration of the PedsQL Generic Quality of Life Inventory and Neuromuscular Module in spinal muscular atrophy (SMA).
    Dunaway S; Montes J; Montgomery M; Battista V; Koo B; Marra J; De Vivo DC; Hynan LS; Iannaccone ST; Kaufmann P
    Neuromuscul Disord; 2010 Mar; 20(3):162-5. PubMed ID: 20074950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gross motor function measure is a valid and sensitive outcome measure for spinal muscular atrophy.
    Nelson L; Owens H; Hynan LS; Iannaccone ST;
    Neuromuscul Disord; 2006 Jun; 16(6):374-80. PubMed ID: 16632361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year.
    Kaufmann P; McDermott MP; Darras BT; Finkel R; Kang P; Oskoui M; Constantinescu A; Sproule DM; Foley AR; Yang M; Tawil R; Chung W; Martens B; Montes J; O'Hagen J; Dunaway S; Flickinger JM; Quigley J; Riley S; Glanzman AM; Benton M; Ryan PA; Irvine C; Annis CL; Butler H; Caracciolo J; Montgomery M; Marra J; Koo B; De Vivo DC; ;
    Arch Neurol; 2011 Jun; 68(6):779-86. PubMed ID: 21320981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.
    Wadman RI; Wijngaarde CA; Stam M; Bartels B; Otto LAM; Lemmink HH; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    Eur J Neurol; 2018 Mar; 25(3):512-518. PubMed ID: 29194869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical evaluator reliability for quantitative and manual muscle testing measures of strength in children.
    Escolar DM; Henricson EK; Mayhew J; Florence J; Leshner R; Patel KM; Clemens PR
    Muscle Nerve; 2001 Jun; 24(6):787-93. PubMed ID: 11360262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of four tests to assess body posture and the range of selected movements in individuals with spinal muscular atrophy.
    Stępień A; Jędrzejowska M; Guzek K; Rekowski W; Stępowska J
    BMC Musculoskelet Disord; 2019 Feb; 20(1):54. PubMed ID: 30732590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The predictive value of achieved motor milestones assessed in 441 patients with infantile spinal muscular atrophy types II and III.
    Rudnik-Schöneborn S; Hausmanowa-Petrusewicz I; Borkowska J; Zerres K
    Eur Neurol; 2001; 45(3):174-81. PubMed ID: 11306862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2-4 (SPACE trial).
    Stam M; Wadman RI; Wijngaarde CA; Bartels B; Asselman FL; Otto LAM; Goedee HS; Habets LE; de Groot JF; Schoenmakers MAGC; Cuppen I; van den Berg LH; van der Pol WL
    BMJ Open; 2018 Jul; 8(7):e019932. PubMed ID: 30061431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy.
    Krosschell KJ; Maczulski JA; Crawford TO; Scott C; Swoboda KJ
    Neuromuscul Disord; 2006 Jul; 16(7):417-26. PubMed ID: 16750368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The test of infant motor performance: reliability in spinal muscular atrophy type I.
    Finkel RS; Hynan LS; Glanzman AM; Owens H; Nelson L; Cone SR; Campbell SK; Iannaccone ST;
    Pediatr Phys Ther; 2008; 20(3):242-6. PubMed ID: 18703961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatropin treatment of spinal muscular atrophy: a placebo-controlled, double-blind crossover pilot study.
    Kirschner J; Schorling D; Hauschke D; Rensing-Zimmermann C; Wein U; Grieben U; Schottmann G; Schara U; Konrad K; Müller-Felber W; Thiele S; Wilichowski E; Hobbiebrunken E; Stettner GM; Korinthenberg R
    Neuromuscul Disord; 2014 Feb; 24(2):134-42. PubMed ID: 24300782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscle strength and motor function in children and adolescents with spinal muscular atrophy II and III.
    Kroksmark AK; Beckung E; Tulinius M
    Eur J Paediatr Neurol; 2001; 5(5):191-8. PubMed ID: 11585107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of muscle strength with a handheld dynamometer in patients with chronic spinal muscular atrophy.
    Febrer A; Rodriguez N; Alias L; Tizzano E
    J Rehabil Med; 2010 Mar; 42(3):228-31. PubMed ID: 20411217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor function-muscle strength relationship in spinal muscular atrophy.
    Merlini L; Bertini E; Minetti C; Mongini T; Morandi L; Angelini C; Vita G
    Muscle Nerve; 2004 Apr; 29(4):548-52. PubMed ID: 15052620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability.
    Glanzman AM; Mazzone E; Main M; Pelliccioni M; Wood J; Swoboda KJ; Scott C; Pane M; Messina S; Bertini E; Mercuri E; Finkel RS
    Neuromuscul Disord; 2010 Mar; 20(3):155-61. PubMed ID: 20074952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. State of the art for motor function assessment tools in spinal muscular atrophy (SMA).
    Vuillerot C
    Arch Pediatr; 2020 Dec; 27(7S):7S40-7S44. PubMed ID: 33357597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.